Prostagladin/prostacyclin analogues vs placebo
QoL · primary Raynaud's phenomenon
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
The review found no eligible studies for this question.
Prostagladin/prostacyclin analogues may leads to higher adverse events (6 weeks' compared with placebo (low certainty).
The review found no eligible studies for this question.